Advertisement

Upper and lower respiratory tract infection

  • Peter Linden
Chapter
  • 32 Downloads

Abstract

Respiratory tract infection, whether acquired in the community or in the hospital, continues to be a major cause of morbidity and mortality when its course requires intensive care support [1–4]. Infections of the respiratory tract may involve either the upper central airways (trachea, major bronchi), commonly termed tracheobronchitis, or the more distal respiratory tract commonly termed “pneumonia”. Pneumonia is defined by the presence of parenchymal inflammation due to overwhelming invasion of the normally sterile lower airways by one or more respiratory pathogens. It is important to categorize pneumonia based on where the infecting organisms were acquired. Community-acquired pneumonia represents only lower respiratory tract infection which was contracted outside the hospital setting, or was incubating at the time of hospitalization. Nosocomial pneumonia is defined as the onset of compatible clinical signs and symptoms with radiographic findings after a minimum of 48 hours of hospitalization, either in an ICU environment or in the general wards.

Keywords

Lower Respiratory Tract Infection Nosocomial Pneumonia Respiratory Pathogen Immunocompromised Host Fiberoptic Bronchoscopy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Garibaldi RA. Epidemiology of community acquired respiratory tract infections in adults. Am J Med 1985; 78 (suppl 6b): 32–7.PubMedCrossRefGoogle Scholar
  2. 2.
    Anonymous. Statistical abstract of the US. 108th ed. Washington, DC: US Dept. of Commerce, Bureau of the Census, 1988.Google Scholar
  3. 3.
    Tones A, Aznar R, Gatell M, Jimenez P, Gonazlez J, Ferrez A, Celis R, Rodriguez-Roisin R. Incidence, risk and prognosis factors of nosocomial pneumonia in mechanically ventilated patients. Am Rev Respir Dis 1990; 142: 523–8.CrossRefGoogle Scholar
  4. 4.
    Gross PA, Van Antwerpen C. Nosocomial infections and hospital deaths: a case-control study. Am J Med 1983; 75: 658–62.PubMedCrossRefGoogle Scholar
  5. 5.
    Craven DE, Steger KA, Barber TW. Preventing nosocomial pneumonia: state of the art and perspectives for the 1990’s. Am J Med 1991; (suppl 3B): 44S–53S.CrossRefGoogle Scholar
  6. 6.
    Horan T, Culver D, Jarvis W, et al.Pathogens causing nosocomial infections. CDC: Antimicrobic Newsletter 1988; 5: 65–7.CrossRefGoogle Scholar
  7. 7.
    Gross PA, Neu HC, Aswapokee P, Van Antwerpen C, et al.Deaths from nosocomial infection: experience in a university hospital and a community hospital. Am J Med 1980; 68: 219–23.PubMedCrossRefGoogle Scholar
  8. 8.
    Craven DE, Kunches LM, Kilinsky V, Lichtenberg DA, Make BJ, McCabe WR. Risk factors for pneumonia and fatality in patients receiving mechanical ventilation. Am Rev Respir Dis 1986; 133: 792–6.PubMedGoogle Scholar
  9. 9.
    Laurenzi GA, Potter RT, Kass EH. Bacteriologic flora of the lower respiratory tract. N Engl J Med 1961; 265: 1273.PubMedCrossRefGoogle Scholar
  10. 10.
    Green G. In defense of the lung. Am Rev Respir Dis 1970; 102: 691–703.PubMedGoogle Scholar
  11. 11.
    Craven DE, Driks MR. Pneumonia in the intubated patient. Semin Respir Infect 1987; 2: 20–33.PubMedGoogle Scholar
  12. 12.
    Johanson W, Pierce AK, Sanford JP, Thomas GD. Nosocomial respiratory infections with gram-negative bacilli: the significance of colonization of the respiratory tract. Ann Intern Med 1972; 77: 701–6.PubMedGoogle Scholar
  13. 13.
    Sleigh MA. Ciliary function in transport of mucus. Eur J Respir Dis 1983; 64 (suppl 128): 287–92.Google Scholar
  14. 14.
    Leith DM. Cough. In: Brain JD, Proctor DF, Reed LM (eds). Respiratory defense mechanisms, Part II. New York, Marcel Dekker, 1977; 545–92.Google Scholar
  15. 15.
    Pulmonary macrophages in nosocomial pneumonia: defense function and dysfunction, and prospects for activation. Eur J Clin Microbiol Infect Dis 1989; 8: 25–8.Google Scholar
  16. 16.
    Kunkel Sl, Steieter RM. Cytokine networking in lung inflammation. Hosp Practice 1990; 25: 63–76.Google Scholar
  17. 17.
    Niederman MS, Ferranti RD, Ziegler A, et al.Respiratory infection complicating long-term tracheostomy: the implication of persistent Gram-negative tracheobronchial colonization. Chest 1984; 85: 39–44.PubMedCrossRefGoogle Scholar
  18. 18.
    Baigelman W, Chodosh S, Pizzuto D, Sadow T. Quantitative sputum Gram stains in chronic bronchial disease. Lung 1979; 156: 265–70.PubMedCrossRefGoogle Scholar
  19. 19.
    Marne TJ, Durant H, Yates L. Community-acquired pneumonia requiring hospitalization: 5-year prospective study. Rev Infect Dis 1980; 11: 586–99.Google Scholar
  20. 20.
    Sorensen J, Forsberg P, Hakanson E, Mailer R, Seder-holm C, Soren L, et al.A new diagnostic approach to the patient with severe pneumonia. Scand J Infect Dis 1989; 21: 33–41.PubMedCrossRefGoogle Scholar
  21. 21.
    Van Eeden SF, Coetzee AR, Joubert JR. Community acquired pneumonia–factors influencing intensive care admissions. S Afr Med J 1988; 73: 77–81.PubMedGoogle Scholar
  22. 22.
    Hook EW, Horton CA, Schaberg DR. Failure of intensive care unit support to influence mortality from pneumococcal bacteremia. JAMA 1983; 249: 1055–7.PubMedCrossRefGoogle Scholar
  23. 23.
    Donowitz GR, Mandell GL. Acute pneumonia. In: Mandell GL, Douglas RG Jr., Bennett JE (eds). Principles and Practice of Infectious Diseases. 3rd ed. New York: Churchill Livingstone, 1990: 540–55.Google Scholar
  24. 24.
    Fang GD, Fine M, Orlott J, et al.New and emerging etiologies for community-acquired pneumonia with implications for therapy. A prospective multicenter study of 359 cases. Medicine (Baltimore) 1990; 69: 307–16.Google Scholar
  25. 25.
    Moine P, Vercken J, Chevret S, Chastang C, Gajdos P, and the French Study Group for Community-Acquired Pneumonia in the Intensive Care Unit. Severe community-acquired pneumonia: etiology, epidemiology and prognosis factors. Chest 1994; 105: 1487–95.PubMedCrossRefGoogle Scholar
  26. 26.
    Appelbaum PC. Antimicrobial resistance in Streptococcus pneumoniae: An overview. Clin Inf Dis 1992; 15: 77–83.CrossRefGoogle Scholar
  27. 27.
    Spika JS, Facklam RR, Plikaytis BD, Oxtoby MJ, The Pneumococcal Surveillance Working Group. Anti-microbial resistance of Streptococcus pneumoniaein the United States 1991; 163: 1273–8.Google Scholar
  28. 28.
    Friedland IR, Med M, McCracken GH. Management of infections caused by antibiotic-resistant Streptococcus pneumoniae. N Engl J Med 1994; 331: 377–82.PubMedCrossRefGoogle Scholar
  29. 29.
    Kaufman CA, Bradley SF, Terrpenning MS. Methicillin-resistant Staphylococcus aureusin long-term care facilities. Infect Control Hosp Epidemiol 1990; 11: 600–3.CrossRefGoogle Scholar
  30. 30.
    Saravolatz LD, Pohlod DJ, Arking LM. Community-acquired methicillin-resistant Staphylococcus aureusinfections: a new source for nosocomial outbreaks. Ann Intern Med 1982; 97: 325–9.PubMedGoogle Scholar
  31. 31.
    Grandados A, Podzamczer D, Guidol F, et al.Pneumonia due to Legionella pneumophilaand pneumococcal pneumonia. Similarities and differences on presentation. Eur Respir J 1989; 2: 130–4.Google Scholar
  32. 32.
    Yu VL, Kroboth FJ, Shonnard J, et al.Legionnaire’s disease: New clinical perspectives from a prospective pneumonia study. Am J Med 1982; 73: 357–61.PubMedCrossRefGoogle Scholar
  33. 33.
    Murray PR, Washington JA II. Microscopic and bacteriologic analysis of expectorated sputum. Mayo Clin Proc 1975; 50: 339–44.PubMedGoogle Scholar
  34. 34.
    Barrett-Connor E. The nonvalue of sputum culture in the diagnosis of pneumococcal pneumonia. Am Rev Respir Dis 1971; 103: 845–8.PubMedGoogle Scholar
  35. 35.
    Levin D, Schwatz M, Matthay R, et al.Bacteremic Hemophilus influenza pneumonia in adults. A report of 24 cases and review of the literature. Am J Med 1977; 62: 219–24.PubMedCrossRefGoogle Scholar
  36. 36.
    Wallace RJ Jr, Musher DM, Martin RR. Haemophilus influenzaepneumonia in adults. Am J Med 1978; 64: 87–93.PubMedCrossRefGoogle Scholar
  37. 37.
    Ortqvist A, Kalin M, Lejdeborn L, Lundberg B. Diagnostic fiberoptic bronchoscopy and protected brush cultures in patients with community-acquired pneumonia. Chest 1990; 97: 576–82.PubMedCrossRefGoogle Scholar
  38. 38.
    Feinsilver SH, Fein AM, Niederman MS, Schultz DE, Faegenburg DH. Utility of fiberoptic bronchoscopy in nonresolving pneumonia. Chest 1990; 98: 1322–6.PubMedCrossRefGoogle Scholar
  39. 39.
    Perlino CA. Laboratory diagnosis and pneumonia due to Streptococcus pneumoniae. J Infect Dis 1985; 150: 139–144.CrossRefGoogle Scholar
  40. 40.
    Haley RW, Hooton TM, Culver DH, et al.Nosocomial infections in US hospitals, 1975–1976: estimated frequency by selected characteristics of patients. Am J Med 1981; 70: 947–59.PubMedCrossRefGoogle Scholar
  41. 41.
    Celis R, Torrres J, Gatell M, Almela R, RodriguezRoisin R, Agusti-Vidal A. Nosocomial pneumonia: a multivariate analysis of risk and prognosis. Chest 1988; 93: 318–24.PubMedCrossRefGoogle Scholar
  42. 42.
    Fagon JY, Chastre Y, Domart Y, et al.Nosocomial pneumonia in patients receiving continuous mechanical ventilation. Am Rev Respir Dis 1989; 139: 877–84.PubMedGoogle Scholar
  43. 43.
    Leu HS, Kaiser DL, Mori M, Woolson F, Wenzel RP. Hospital acquired pneumonia: attributable mortality and morbidity. Am J Epidemiol 1989; 129: 1258–67.PubMedGoogle Scholar
  44. 44.
    Fagon JY, Chastre J, Hance A, Montravers P, Novara A, Gibert C. Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. Am J Med 1993; 94: 281–8.PubMedCrossRefGoogle Scholar
  45. 45.
    Bryan CS, Reynolds KL. Bacteremic nosocomial pneumonia: analysis of 172 episodes from a single metropolitan area. Am Rev Respir Dis 1984; 129: 668–71.PubMedGoogle Scholar
  46. 46.
    Johanson WG Jr, Pierce AK, Sanford JP. Nosocomial respiratory infections with gram-negative bacilli: the significance of colonization of the respiratory tract. Ann Intern Med 1972; 77: 701–6.PubMedGoogle Scholar
  47. 47.
    Johanson WG Jr, Higuchi JC, Chaudhuri TR, Woods DE. Bacterial adherence to epithelial cells in bacillary colonization of the respiratory tract. Am Rev Respir Dis 1980; 121: 55–63.PubMedGoogle Scholar
  48. 48.
    Niederman MS, Rafferty TS, Sasaki CT, Merrill WM, Matthay RA, Reynolds HY. Nutritional status and bacterial binding in the lower respiratory tract in patients with chronic tracheostomy. Ann Intern Med 1984; 100: 795–800.PubMedGoogle Scholar
  49. 49.
    Woods DE, Straus DC, Johanson WG Jr, Bass JA. Role of fibronectin in the prevention of adherence of Pseudomonas aeruginosato buccal cells. J Infect Dis 1981; 143: 784–90.PubMedCrossRefGoogle Scholar
  50. 50.
    Woods DE, Straus DC, Johanson WG Jr, Berry VK, Bass JA. Role of pili in adherence of Pseudomonas aeruginosato mammalian buccal epithelial cells. Infect Immun 1980; 29: 1146–51.PubMedGoogle Scholar
  51. 51.
    Bartlett JG, Finegold SM. Bacteriology of expectorated sputum with quantitative culture and wash technique compared to transtracheal aspirated. Am Rev Respir Dis 1978; 117: 1019–27.PubMedGoogle Scholar
  52. 52.
    de Moulin GC, Hedley-Whyte J, Paterson DG, Lisbon A. Aspiration of gastric bacteria in antacid-treated patients: a frequent cause of postoperative colonization of the airway. Lancet 1982; 1: 242–5.PubMedGoogle Scholar
  53. 53.
    Driks MR, Craven DE, Celli BR, et al.Nosocomial pneumonia in intubated patients given sucralfate as compared with antacids of histamine type 2 blockers: the role of gastric colonization. N Engl J Med 1987; 317: 1376–82.PubMedCrossRefGoogle Scholar
  54. 54.
    Donowitz GL, Page ML, Mileur BL, Guenther SH. Alteration of normal gastric flora in critical care patients receiving antacid and cimetidine therapy. Infect Control 1986; 7: 23–6.PubMedGoogle Scholar
  55. 55.
    Tryba M. Sucralfate versus antacids or H2-antagonists for stress ulcer prophylaxis: a meta-analysis on efficacy and pneumonia rate. Crit Care Med 1991; 19: 942–9.PubMedCrossRefGoogle Scholar
  56. 56.
    Pingleton SK, Hinthorn DP, Liu C. Enteral nutrition in patients receiving mechanical ventilation: multiple sources of tracheal colonization include the stomach. Am J Med 1986; 80: 827–30.PubMedCrossRefGoogle Scholar
  57. 57.
    Jacobs S, Chang RW, Lee B, Bartlett FW. Continuous enteral feedings: a major cause of pneumonia among ventilated intensive care unit patients. Parenteral Nutrition 1990; 14: 353–6.CrossRefGoogle Scholar
  58. 58.
    Weinstein RA. Epidemiology and control of nosocomial infections in adult intensive care units. Am J Med 1991; 91 (3B): 179S–84S.PubMedCrossRefGoogle Scholar
  59. 59.
    Chow JW, Fine MJ, Shlaes DM, et al.Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy. Ann Intern Med 1991; 115: 585–90.PubMedGoogle Scholar
  60. 60.
    Fagon JY, Chastre J, Domart Y, et al.Nosocomial pneumonia in patients receiving continuous mechanical ventilation. Prospective analysis of 52 episodes with use of a protected specimen brush and quantitative culture techniques. Am Rev Respir Dis 1989; 139: 877–84.PubMedGoogle Scholar
  61. 61.
    Maki DG. Control of colonization and transmission of pathogenic bacteria in the hospital. Ann Intern Med 1978; 89: 777–80.PubMedGoogle Scholar
  62. 62.
    Craven DE, Lichtenberg DA, Goularte TA, Make BJ. Contaminated medication nebulizers in mechanical ventilator circuits: a source of bacterial aerosols. Am J Med 1984; 77: 834–8.PubMedCrossRefGoogle Scholar
  63. 63.
    Huxley EJ, Viroslav J, Gray WR, Pierce AK. Pharyngeal aspiration in normal adults and patients with depressed consciousness. Am J Med 1978; 64: 564–8.PubMedCrossRefGoogle Scholar
  64. 64.
    Torres A, Serra-Battles J, Ros E, et al.Pulmonary aspiration of gastric contents in patients receiving mechanical ventilation: the effect of body position. Ann Intern Med 1992; 1 16: 540–3.Google Scholar
  65. 65.
    Inglis TJ, Millar MR, Jones G, Robinson DA. Tracheal tube biofilm as a source of bacterial colonization of the lung. J Clin Microbiol 1989; 27: 2014–8.PubMedGoogle Scholar
  66. 66.
    Sottile FD, Marrie TJ, Prough DS, et al.Nosocomial pulmonary infection: possible etiologic significance of bacterial adhesion to endotracheal tubes. Crit Care Med 1986; 14: 265–70.PubMedCrossRefGoogle Scholar
  67. 67.
    Centers for Disease Control. National Nosocomial Infections Study Report. Annual Summary: 1984. MMWR 1986; 35: 17 SS-29 SS.Google Scholar
  68. 68.
    Rouby JJ, Martin-DeLassale E, Poete P, et al.Nosocomial bronchopneumonia in the critically ill: histologic and bacteriologic aspects. Am Rev Respir Dis 1992; 146: 1059–66.PubMedGoogle Scholar
  69. 69.
    Fagon JY, Chastre A, Hance J, et al.Detection of nosocomial lung infection in ventilated patients: use of a protected specimen brush and quantitative culture techniques in 147 patients. Am Rev Respir Dis 1988; 138: 110–6.PubMedCrossRefGoogle Scholar
  70. 70.
    Bartlett JG, O’Keefe P, Tally FP, Louie TJ, Gorbach SL. Bacteriology of hospital-acquired pneumonia. Arch Intern Med 1986; 146: 868–71.PubMedCrossRefGoogle Scholar
  71. 71.
    Kirby BD, Synder KM, Meyer RD, et al.Legionnaire’s disease: Report of sixty-five nosocomially acquired cases and review of the literature. Medicine 1980; 59: 188–205.PubMedCrossRefGoogle Scholar
  72. 72.
    Muder RR, Yu VL. Mode of transmission of Legionella pneumophilapneumonia. Arch Intern Med 1986; 146: 1607–12.PubMedCrossRefGoogle Scholar
  73. 73.
    Rello J, Quintana E, Ausina V, Puzo C, Net A, Prats G. Risk factors for Staphylococcus aureusnosocomial pneumonia in critically ill patients. Am Rev Respir Dis 1990; 142: 1320–4.PubMedGoogle Scholar
  74. 74.
    Rello J, Torres A, Ricart M, et al.Ventilator-associated pneumonia by Staphylococcus aureus: comparison of methicillin-resistant and methicillin-sensitive episodes. Am J Respir Crit Care Med 1994; 150: 1545–9.PubMedGoogle Scholar
  75. 75.
    Bryant LR, Mobin-Uddin K, Dillon ML, Griffen WO, Ky L. Misdiagnosis of pneumonia in patients needing mechanical ventilation. Arch Surg 1973; 106: 286–8.PubMedCrossRefGoogle Scholar
  76. 76.
    Andrews CP, Coalson JJ, Smith JD, et al.Diagnosis of nosocomial bacterial pneumonia in acute diffuse lung injury. Chest 1981; 80: 254–8.PubMedCrossRefGoogle Scholar
  77. 77.
    Bell RC, Coalson JJ, Smith JD, et al.Multiple organ system failure and infection in adult respiratory distress syndrome. Ann Intern Med 1983; 99: 293–8.PubMedGoogle Scholar
  78. 78.
    Joshi M, Cisela N, Caplan E. Diagnosis of pneumonia in critically ill patients. Chest 1988; 94: 4SGoogle Scholar
  79. 79.
    Seidenfeld JJ, Pohl DF, Bell RC, Harris GD, Johanson WJ Jr. Incidence, site and outcome of infections in patients with the adult respiratory distress syndrome. Am Rev Respir Dis 1986; 134: 12–6.PubMedGoogle Scholar
  80. 80.
    Berger R, McConnell JW, Phillips B, Overman TL. Diagnostic value of the Gram stain of expectorated sputum in bacterial pneumonias: a pilot study [abstract] Am Rev Respir Dis 1988; 135: A219.Google Scholar
  81. 81.
    Salata RA, Lederman MM, Shlaes DM, et al.Diagnosis of nosocomial pneumonia in intubated, intensive care unit patients. Am Rev Respir Dis 1987; 135: 426–32.PubMedGoogle Scholar
  82. 82.
    Craven DE, Kunches LM, Lichtenberg DA, et al.Nosocomial infection and fatality in medical and surgical intensive care unit patients. Arch Intern Med 1988; 148: 1161–8.PubMedCrossRefGoogle Scholar
  83. 83.
    Baigelman W, Bellin S, Cupples A, Berenberg MJ. Bacteriologic assessment of the lower respiratory tract in intubated patients. Crit Care Med 1989; 17: 864–8.Google Scholar
  84. 84.
    Marquette CH, Georges H, Wallet F, et al.Diagnostic efficiency of endotracheal aspirates with quantitative bacterial cultures in intubated patients with suspected pneumonia: comparison with the protected specimen brush. Am Rev Respir Dis 1993; 148: 138–44.PubMedGoogle Scholar
  85. 85.
    Bartlett JG, Alexander J, Mayhew J, et al.Should fiberoptic bronchoscopy aspirates be cultured? Am Rev Respir Dis 1976; 114: 247–51.Google Scholar
  86. 86.
    Wimberley N, Faling LJ, Bartlett JG. A fiberoptic bronchoscoopy technique to obtain uncontaminated lower airway secretions for bacterial culture. Am Rev Respir Dis 1979; 119: 337–43.PubMedGoogle Scholar
  87. 87.
    Chastre J, Viau F, Brun P, et al.Prospective evaluation of the protected specimen brush for the diagnosis of pulmonary infections in ventilated patients. Am Rev Respir Dis 1984; 130: 924–9.PubMedGoogle Scholar
  88. 88.
    Fitzgerald JM, Cook DJ, Oxman A, Guyatt GH. The role of the protected brush catheter and bronchoalveolar lavage in the diagnosis of pneumonia. Am Rev Respir Dis 1991; 143 (4): A108Google Scholar
  89. 89.
    Jett JR, Cortese DA, Dines DE. The value of bronchoscopy in the diagnosis of mycobacterial disease. Chest 1981; 80: 575–8.PubMedCrossRefGoogle Scholar
  90. 90.
    Chastre J, Fagon JY, Soler P, et al.Diagnosis of nosocomial bacterial pneumonia in intubated patients undergoing ventilation: comparison of the usefulness of bronchoalveolar lavage and the protected specimen brush. Am J Med 1988; 85: 499–506.PubMedCrossRefGoogle Scholar
  91. 91.
    Chastre J, Fagon JY, Soler P, et al. Quantification of BAL cells containing intracellular bacteria rapidly identifies ventilated patients with nosocomial pneumonia. Chest 1989; 95: 190S–92S.CrossRefGoogle Scholar
  92. 92.
    Griffin JJ and Meduri GU. New approaches in the diagnosis of nosocomial pneumonia. Med Clin North Am 1994; 78: 1091–1122.PubMedGoogle Scholar
  93. 93.
    Torres A, De La Bellacasa JP, Xaubet A, et al.Diagnostic value of quantitative cultures of bronchoalveolar lavage and telescoping plugged catheters in mechanically ventilated patients with bacterial pneumonia. Am Rev Respir Dis 1989; 140: 306–10.PubMedCrossRefGoogle Scholar
  94. 94.
    Meduri GU, Beals D, Maiijub G, Baselski V. Protected bronchoalveolar lavage: a new bronchoscopic technique to retrieve uncontaminated distal airway secretions. Am Rev Respir Dis 1991; 143: 855–64.PubMedGoogle Scholar
  95. 95.
    Johanson WG Jr, Seidenfeld JJ, Gomez P, De Los Santos R, Coalson JJ. Bacteriologic diagnosis of nosocomial pneumonia following prolonged mechani-cal ventilation. Am Rev Respir Dis 1989; 140: 30610.Google Scholar
  96. 96.
    Guera LF, Baughman RP. Use of bronchoalveolar lavage to diagnose bacterial pneumonia in mechanically ventilated patients. Crit Care Med 1990; 18: 16973.Google Scholar
  97. 97.
    Kahn FW, Jones JM. Diagnosing bacterial respiratory infection by bronchoalveolar lavage. J Infect Dis 1987; 155: 862–9.PubMedCrossRefGoogle Scholar
  98. 98.
    Dreyfuss D, Mier L, Le Bourdelles G, et al.Clinical significance of borderline quantitative protected brush specimen culture results. Am Rev Respir Dis 1993; 147: 941–51.Google Scholar
  99. 99.
    Tillotson JR, Finland M. Bacterial colonization and clinical superinfection of the respiratory tract complicating antibiotic treatment of pneumonia. J Infect Dis 1969; 119: 597–624.PubMedCrossRefGoogle Scholar
  100. 100.
    Niederman MS. An approach to empiric therapy of nosocomial pneumonia. Med Clin North Am 1994; 78: 1123–41.PubMedGoogle Scholar
  101. 101.
    Pennington JE. Penetration of antibiotics in respiratory secretions. Rev Infect Dis 1981; 3: 67–73.PubMedCrossRefGoogle Scholar
  102. 102.
    Moore RD, Smith CR, Lietman PS. Association of aminoglycoside plasma levels with therapeutic outcome in Gram-negative pneumonia. Am J Med 1984; 77: 657–62.PubMedCrossRefGoogle Scholar
  103. 103.
    Hilf M, Yu VL, Sharp J, Zuravleff JJ, Korvick JA, and Muder RR. Antibiotic therapy for Pseudomonas aeruginosabacteremia: outcome correlations in a prospective study of 200 patients. Am J Med 1989; 87: 540–46.PubMedCrossRefGoogle Scholar
  104. 104.
    LaForce FM. Systemic antimicrobial therapy of nosocomial pneumonia: monotherapy versus combination therapy. Eur J Clin Microbiol Infect Dis 1989; 8: 61–8.PubMedCrossRefGoogle Scholar
  105. 105.
    Fink MP, Snydman DR, Niederman MS, et al.Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized double-blind trial comparing intravenous ciprofloxacin with imipenemcilastatin. The Severe Pneumonia Study Group. Antimicrob Agents Chemother 1994; 38: 547–57.PubMedCrossRefGoogle Scholar
  106. 106.
    Silver DR, Cohen IL, Weinberg PF. Recurrent Pseudomonas aeruginosapneumonia in an intensive care unit. Chest 1992; 194–8.Google Scholar
  107. 107.
    Stratton C. Fluoroquinolone antibiotics: properties of the class and individual agents. Clin Ther 1992; 14: 348–75.PubMedGoogle Scholar
  108. 108.
    Dreyfuss D, Djedaini K, Weber K, et al.Prospective study of nosocomial pneumonia and of patient and circuit colonization during mechanical ventilation with circuit changes every 48 hours versus no change. Am Rev Respir Dis 1991; 143: 738–43.PubMedGoogle Scholar
  109. 109.
    Dreyfuss D, Djedaini K, Gros I, et al.Mechanical ventilation with heated humidifiers or heat and moisture exchangers: effect on patient colonization and incidence of nosocomial pneumonia. Am J Respir Crit Care Med 1995; 151: 986–92.PubMedGoogle Scholar
  110. 110.
    Valles J, Artigas A, Rello J, et al.Continuous aspiration of subglottic secretions in preventing ventilator-associated pneumonia. Ann Intern Med 1995; 122: 179–86.PubMedGoogle Scholar
  111. 111.
    Selective Decontamination of the Digestive Tract Trialist’s Collaborative Group. Meta-analysis of ran-domised controlled trials of selective decontamination of the digestive tract. Brit Med J 1993; 307: 525–32.CrossRefGoogle Scholar
  112. 112.
    Greenfield S, Teres D, Bushnell CS, et al.Prevention of Gram-negative bacillary pneumonia using aerosol polymyxin as prophylaxis. J Clin Invest 1973; 52: 2935–40.PubMedCrossRefGoogle Scholar
  113. 113.
    Klatersky J, Huysmans E, Weerts D, et al.Endotracheally administered gentamicin for prevention of infections of the respiratory tract in patients with tracheostomy. A double blind study. Chest 1974; 65: 6504.Google Scholar
  114. 114.
    Feely TW, DuMoulin GC, Hedley-Whyte J, Bushnell LS, Gilbert JP, Feingold DS. Aerosol polymyxin and pneumonia in seriously ill patients. N Engl J Med 1975; 293: 471–5.CrossRefGoogle Scholar
  115. 115.
    Pizzo PA. Management of fever in patients with cancer and treatment induced neutropenia. N Engl J Med 1993; 328: 1323–32.PubMedCrossRefGoogle Scholar
  116. 116.
    Hughes WT, Armstrong D, Bodey GP, et al.Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. J Infect Dis 1990; 161: 381–96.PubMedCrossRefGoogle Scholar
  117. 117.
    Pizzo PA, Hathorn JW, Hiemenz J, et al.A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia. N Engl J Med 1986; 315: 552–8.PubMedCrossRefGoogle Scholar
  118. 118.
    Gerson SL, Talbot GH, Hurwitz S, et al.Prolonged granulocytopenia The major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia. Ann Intern Med 1984; 100: 345–51.PubMedGoogle Scholar
  119. 119.
    Rubin RH, Wolfson JS, Cosimi AB, et al.Infection in the renal transplant recipient. Am J Med 1981; 70: 405–11.PubMedCrossRefGoogle Scholar
  120. 120.
    Peterson PK Balfour HH, Fryd DS, et al.Fever in renal transplant recipients: causes, prognostic significance and changing patterns at the University of Minnesota. Am J Med 1981; 345–51.Google Scholar
  121. 121.
    Kusne S, Dummer JS, Ho M, et al.Infections after liver transplantation: an analysis of 101 consecutive cases. Medicine 1988; 67: 132–43.PubMedCrossRefGoogle Scholar
  122. 122.
    Singh N, Dummer JS, Ho M, et al.Infections with cytomegalovirus and other Herpesviruses in 121 liver transplant recipients: Transmission by donated organ and the effect of OKT3 antibodies. J Infect Dis 1988; 154: 124–31.CrossRefGoogle Scholar
  123. 123.
    Fanta CH, Pennington JE. Pulmonary infections in the transplant patient. In: Morris PJ, Tilney NL (eds). Progress in Transplantation vol 2. New York, Churchill Livingstone, 1985, 207–30.Google Scholar
  124. 124.
    Dummer JS, Montero CG, Griffith BP, et al.Infection in heart-lung transplant recipients. Transplantation 1986; 41: 725–9.PubMedCrossRefGoogle Scholar
  125. 125.
    Snydman DR. Treatment of cytomegalovirus pneumonia in solid organ recipients. In: Ganciclovir Therapy for CytomegalovirusInfection. Spector S (ed). New York, Marcel Dekker, 1991, 145.Google Scholar
  126. 126.
    Dummer JS. Pneumocystis carinii infections in transplant recipients. Sem Respir Infect 1990; 5: 50–7.Google Scholar
  127. 127.
    Singer C, Armstrong D, Rosen PP, et al.Diffuse pulmonary infiltrates in immunosuppressed patients: prospective study of 80 cases. Am J Med 1979; 66: 110–20.PubMedCrossRefGoogle Scholar
  128. 128.
    Hoover DR, Saah AJ, Bacellar H. Clinical mani-festations of AIDS in the era of pneumocystis prophylaxis. N Engl J Med 1993; 329: 1922–6.PubMedCrossRefGoogle Scholar
  129. 129.
    Selwyn PA, Feingold AR, Hartel D, et al.Increased risk of bacterial pneumonia in HIV-infected intravenous drug users without AIDS. AIDS 1988; 2: 267–72.PubMedCrossRefGoogle Scholar
  130. 130.
    Dummer JS. Pneumocystis carinii infections in transplant recipients. Sem Respir Infect 1990; 5: 50–7.Google Scholar
  131. 131.
    Singer C, Armstrong D, Rosen PP, et al.Diffuse pulmonary infiltrates in immunosuppressed patients: prospective study of 80 cases. Am J Med 1979; 66: 110–20.PubMedCrossRefGoogle Scholar
  132. 132.
    Glenn RW, Pierson DG. Cost reduction in diagnosing Pneumocystis cariniipneumonia–sputum induction versus bronchoalveolar lavage as the initial diagnostic procedure. Am Rev Respir Dis 1992; 145: 1425–8.Google Scholar
  133. 133.
    Williams DE, Yungblth M, Adams G, et al.The role of fiberoptic bronchoscopy in the evaluation of immunocompromised hosts with diffuse pulmonary infiltrates. Am Rev Respir Dis 1985; 131: 880–5.PubMedGoogle Scholar
  134. 134.
    Stover DE, Zaman MB, Hajdu SI, et al.Bronchoalveolar lavage in the diagnosis of diffuse pulmonary infiltrates in the immunosuppressed host. Ann Intern Med 1984; 101: 1–7.PubMedGoogle Scholar
  135. 135.
    Springmeyer SC, Hackman RC, Holle R, et al.Use of bronchoalveolar lavage to diagnose acute diffuse pneu-monia in the immunocompromised host. J Infect Dis 1986; 154: 604–10.PubMedCrossRefGoogle Scholar
  136. 136.
    Hopkin JM, Turney JH, Young JA, et al.Rapid diagnosis of obscure pneumonia in immunosuppressed renal patients by cytology of alveolar lavage fluid. Lancet 1983; 2: 229–301.Google Scholar
  137. 137.
    DeGracia J, Curull V, Vidal R, Riba A, Oriols R. Diagnostic value of bronchoalveolar lavage in suspected pulmonary tuberculosis. Chest 1988; 93: 3 2932.Google Scholar
  138. 138.
    Baughman RP, Dohn MN, Loudon RG, Frame PT. Bronchoscopy with bronchoalveolar lavage in tuberculosis and fungal infections. Chest 1991; 99: 92–7.PubMedCrossRefGoogle Scholar
  139. 139.
    Cockerill FR III, Wilson WR, Carpenter HA, et al.Open lung biopsy in immunocompromised patients. Arch Intern Med 1985; 145: 1398–404.PubMedCrossRefGoogle Scholar
  140. 140.
    Thomas JH, Farek PE, Hermreck AS, Pierce GE. Diagnostic value of open lung biopsy in immunocompromised patients. Amer J Surg 1987; 15: 692–5.CrossRefGoogle Scholar
  141. 141.
    Rossiter SJ, Miller DC, Churg AM, et al.Open lung biopsy in the immunosuppressed patient: Is it really beneficial? J Thorac Cardiovasc Surg 1979; 77: 33845.Google Scholar
  142. 142.
    Sanford JP, Gilbert DN, Sande M. The Sanford Guide to Antimicrobial Therapy. 26th Edition. Sanford JP (ed.), Dallas, Texas, 1996.Google Scholar

Copyright information

© Springer Science+Business Media Dordrecht 1998

Authors and Affiliations

  • Peter Linden

There are no affiliations available

Personalised recommendations